相似文献
1
AN UNIDENTIFIED, FILTRABLE AGENT ISOLATED FROM TRANSPLANTED HUMAN TUMORS.
Proc Natl Acad Sci U S A. 1960 Sep;46(9):1256-8. doi: 10.1073/pnas.46.9.1256.
2
An Unidentified, Filtrable Agent Isolated From the Feces of Children With Paralysis.
Science. 1948 Jul 16;108(2794):61-2. doi: 10.1126/science.108.2794.61.
3
Filtrable virus-like agent isolated from tumors induced by carcinogenic substances.
Folia Biol (Praha). 1962 Feb;8:7-11.
4
[Significance of various biological factors in the action of the filtrable agent from mouse tumors].
Strahlentherapie. 1957;15(Sonderbd. 37):116-7.
5
Filtrable forms of mycobacteria tuberculosis.
Z Erkr Atmungsorgane. 1984;162(2):147-54.
6
IDENTIFICATION OF THE FILTRABLE, TRANSMISSIBLE NEUROLYTIC AGENT ISOLATED FROM TOXOPLASMA-INFECTED TISSUE AS A NEW PLEUROPNEUMONIA-LIKE MICROBE.
Science. 1938 Dec 16;88(2294):575-6. doi: 10.1126/science.88.2294.575.
7
[Specific agent inducing rheumatism. I. Certain data on filtrable virus isolated in rheumatism].
Ter Arkh. 1958 May;30(5):3-15.
8
A filtrable agent producing lymphoid tumors and osteopetrosis in chickens.
Cancer Res. 1946 Apr;6:189-96.
9
Tumor induction in Swiss mice by filtrable agent and Salmonella typhimurium.
Acta Med Okayama. 1979 Oct;33(5):405-7.
10
[Filtrable forms of Bact. breslau. I. Method of obtaining and regeneration of filtrable forms].
Mikrobiol Zh. 1955;17(2):7-10.
引用本文的文献
1
Mapping the sialic acid-binding sites of LuIII and H-1 parvovirus.
J Virol. 2025 Aug 19;99(8):e0029725. doi: 10.1128/jvi.00297-25. Epub 2025 Jul 24.
2
The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.
Pathogens. 2024 Feb 20;13(3):184. doi: 10.3390/pathogens13030184.
3
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer.
Front Oncol. 2022 May 24;12:875188. doi: 10.3389/fonc.2022.875188. eCollection 2022.
4
Small but mighty: old and new parvoviruses of veterinary significance.
Virol J. 2021 Oct 24;18(1):210. doi: 10.1186/s12985-021-01677-y.
5
Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers.
Cancers (Basel). 2021 Jan 19;13(2):342. doi: 10.3390/cancers13020342.
6
Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.
Cancers (Basel). 2019 Dec 7;11(12):1975. doi: 10.3390/cancers11121975.
7
H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future.
Viruses. 2019 Jun 18;11(6):562. doi: 10.3390/v11060562.
8
Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.
Front Bioeng Biotechnol. 2015 Apr 22;3:55. doi: 10.3389/fbioe.2015.00055. eCollection 2015.
9
Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids.
J Virol. 2013 May;87(9):5128-40. doi: 10.1128/JVI.03416-12. Epub 2013 Feb 28.
10
Simian parvoviruses: biology and implications for research.
Comp Med. 2008 Feb;58(1):47-50.
本文引用的文献
1
Experimental production of mongoloid hamsters.
Science. 1960 May 13;131(3411):1446-8. doi: 10.1126/science.131.3411.1446.
2
Observations on the heterologous transplantation of human tumors.
Cancer Res. 1958 May;18(4):485-7.
3
Permanently transplantable human tumors maintained in conditioned heterologous hosts: H. Chon. #1, H. Ep. #4, and H. Ad. #1.
Cancer Res. 1957 Jun;17(5):418-20.
Zotero 插件